Functional consequences of sequence alterations in the ATM gene

DNA Repair

Volumn 3, Issue 8-9, 2004, Pages 1197-1205

  Lavin, Martin F ^a,b   Scott, Shaun ^a   Gueven, Nuri ^a   Kozlov, Sergei ^a,b   Peng, Cheng ^a   Chen, Philip ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Ataxia telangiectasia; ATM gene; Functional domains; Missense mutations; Radiation signaling

Indexed keywords

ATM PROTEIN; GENE PRODUCT; PROTEIN KINASE;

AMINO ACID SEQUENCE; ATAXIA TELANGIECTASIA; ATM GENE; CANCER SUSCEPTIBILITY; CARBOXY TERMINAL SEQUENCE; DNA STRAND BREAKAGE; GENE; GENE FUNCTION; GENE SEQUENCE; HETEROZYGOTE; HUMAN; MISSENSE MUTATION; MOLECULAR RECOGNITION; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; RADIOSENSITIVITY; REVIEW; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; CELL CYCLE PROTEINS; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; GENES, DOMINANT; HETEROZYGOTE; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; RADIATION TOLERANCE; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 3242879267     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dnarep.2004.03.011     Document Type: Review

References (73)

1. Ward L.F. Molecular mechanisms of radiation-induced damage to nucleic acids. Radiat. Res. 86:1975;185-195
2. Collins M., M Myers R. Alterations in DNA helix stability due to base modifications can be evaluated using denaturing gradient gel electrophoresis. J. Mol. Biol. 198:1987;737-744
3. E Haber J. Partners and pathways repairing a double strand break. Trends Genet. 16:2000;259-264
4. Iliakis G., Wang Y., Guan J., Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene. 22:2003;5834-5847
5. F Lavin M., Shiloh Y. The genetic defect in ataxia-telangiectasia. Annu. Rev. Immunol. 15:1997;177-202
6. Shiloh Y., Kastan M.B. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83:2001;209-254
7. Bakkenist C.J., B Kastan M. DNA damage activates ATM through intermolecular autophosphorylation and dimer association. Nature. 421:2003;499-506
8. Kozlov S., Gueven N., Keating K., Ramsay J., Lavin M.F. ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J. Biol. Chem. 278:2003;9309-9317
9. Andegeko Y., Moya L., Mittelman L., Tsarfaty I., Shiloh Y., Rotman G. Nuclear retention of ATM at sites of DNA double strand breaks. J. Biol. Chem. 276:2001;38224-38230
10. Shafman T., Khanna K.K., Kedar P., Spring K., Kozlov S., Yen T., Hobson K., Gatei M., Zhang N., Watters D., Egerton M., Shiloh Y., Kharbanda S., Kufe D., Lavin M.F. Interaction between ATM protein and c-Abl in response to DNA damage. Nature. 387:1997;520-523
11. Chen S., Paul P., D Price B. ATM's leucine-rich domain and adjacent sequences are essential for ATM to regulate the DNA damage response. Oncogene. 22:2003;6332-6339
12. Beamish H., Kedar P., Kaneko H., Chen P., Fukao T., Peng C., Beresten S., Gueven N., Purdie D., Lees-Miller S., Ellis N., Kond N., Lavin M.F. Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia- mutated protein, ATM. J. Biol. Chem. 277:2002;30515-30523
13. Turrene G.A., Paul P., Laflair L., Price B.D. Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene. 20:2001;5100-5110
14. C Chen P., F Lavin M., Kidson C., Moss D. Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature. 274:1978;484-486
15. Swift M. Public health burden of cancer in ataxia-telangiectasia heterozygotes. J. Natl. Cancer Inst. 2:2001;84-85
16. Gatti A., Tward A., Concannon P. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncatin mutations. Mol. Genet. Metab. 68:1999;419-423
17. Lim D.S., Kim S.T., Xu B., S Maser R., Lin J., H Petrini J., Kastan M.B. ATM phosphorylates p95/Nbs1 in an S-phase checkpoint pathway. Nature. 404:2000;613-617
18. P Scott S., Bendix R., Chen P., Clark R., Dork T., Lavin M.F. Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer. Proc. Natl. Acad. Sci. U.S.A. 99:2002;925-930
19. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Fryman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor A.M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single ataxia-telangiectasia gene with a product similar to Pl-3 kinase. Science. 268:1995;1749-1753
20. Platzer M., Rotman G., Uziel D., Savitsky K., Bar-Shira A., Gilad S., Shiloh Y., Rosenthal A. Ataxia-telangiectasia locus:sequence analysis of 184 kb of human genomic DNA containing the entire ATM gene. Genome Res. 6:1997;592-605
21. Lavin M.F., K Khanna K., Beamish H., Spring K., Watters D., Shiloh Y. Relationship of the ataxia-telangiectasia protein ATM to phosphoinositide 3-kinase. Trends Biochem. Sci. 20:1995;382-383
22. Zakian V.A. ATM-related genes: what do they tell us about functions of the human gene? Cell. 82:1995;685-687
23. Durocher D., Jackson S.P. DNA-PK, ATM and ATR as sensors of DNA damage: variations on a theme? Curr. Opin. Cell Biol. 2:2001;225-231
24. Bosotti R., Isacchi A., Sonnhammer E.L. FAT: a novel domain in PIK-related kinases. Trends Biochem. Sci. 25:2000;225-227
25. Watters D., Khanna K.K., Beamish H., Birrell G., Spring K., Kedar P., Gatei M., Stenzel D., Hobson K., Kozlov S., Zhang N., Farrell A., Ramsay J., Gatti R., Lavin M.F. Cellular localization of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. Oncogene. 14:1997;1911-1921
26. Watters D., Kedar P., Spring K., Bjorkman J., Chen P., Gatei M., Birrell G., Garrone B., Srinivasa P., Crane D.I., Lavin M.F. Localization of a portion of extranuclear ATM to peroxisomes. J. Biol. Chem. 274:1999;34277-34282
27. Subramani S. Protein import into peroxisomes and biogenesis of the organelle. Annu. Rev. Cell. Biol. 9:1993;445-478
28. Groves M.R., Barford D. Topological characteristics of helical repeat proteins. Curr. Opin. Struct. Biol. 9:1999;383-389
29. Morgan S.E., Lovly C., Pandita T.K., Shiloh Y., Kastan M.B. Fragments of ATM which have dominant-negative or complementing activity. Mol. Cell. Biol. 17:1997;2020-2029
30. Khanna K.K., Keating K.E., Kozlov S., Scott S., Gatei M., Hobson K., Taya Y., Gabrielli B., Chan D., Lees-Miller S.P., Lavin M.F. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat. Genet. 20:1998;398-400
31. Gatei M., Scott S.P., Filippovitch I., Sorokina N., Lavin M.F., Weber B., Khanna K.K. Role for ATM in DNA damage-induced phosphorylation of BRCA1. Cancer Res. 60:2000;3299-3304
32. Perrry J., Kleckner N. The ATRs, ATMs, and TORs are giant HEAT repeat proteins. Cell. 2:2003;151-155
33. Lim D.S., Kirsch D.G., Canman C.E., Ahn J.H., Ziv Y., Newman L.S., Darnell R.B., Shiloh Y., Kastan M.B. ATM binds to β-adaptin in cytoplasmic vesicles. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10146-10151
34. O'Connor R.D., Linthicum D.S. Mitogen receptor redistribution defects and concomitant absence of blastogenesis in ataxia-telangiectasia T lymphocytes. Clin. Immunol. Immunopathol. 15:1980;66-75
35. Barlow C., Ribaut-Barassin C., Zwingman T.A., Pope A.J., Brown K.D., Owens J.W., Larson D., Harrington E.A., Haeberle A.M., Mariani J., Eckhaus M., Herrup K., Bailly Y., Wynshaw-Boris A. ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc. Natl. Acad. Sci. U.S.A. 97:2000;871-876
36. Oka A., Takashima S. Expression of the ataxia-telangiectasia gene (ATM) product in human cerebellar neurons during development. Neurosci. Lett. 252:1998;195-198
37. Smith G.C., Cary R.B., Lakin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia- telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 20:1999;11134-11139
38. Llorca O., Rivera-Calzada A., Grantham J., Willison K.R. Electron microscopy and 3D reconstructions reveal that human ATM kinase uss an arm-like domain to clamp around double-stranded DNA. Oncogene. 22:2003;3867-3874
39. Hannan M.A., Hellani A., Al-Khondairy F.M., Kunhi M., Siddiqui Y., Al-Yussef N., Pangue-Cruz N., Siewertsen M., Al-Ahdal M.N., Aboussekhra A. Deficiency in the repair of UV-induced DNA damage in human skin fibroblasts compromised for the ATM gene. Carcinogenesis. 23:2002;1617-1624
40. Ha L., Ceryak S., Patierno S.R. Chromium (VI) activates ataxia telangiectasia mutated (ATM) protein. Requirement of ATM for both apoptosis and recovery from terminal growth arrest. J. Biol. Chem. 278:2003;17885-17894
41. Hofseth L.J., Saito S., Hussain S.P., Espey M.G., Miranda K.M., Araki Y., Jhappan C., Higashimoto Y., He P., Linke S.P., Quezado M.M., Zurer I., Rotter V., Wink D.A., Appella E., Harris C.C. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc. Natl. Acad. Sci. U.S.A. 100:2003;143-148
42. Suzuki A., Kusakai G., Kishimoto A., Lu J., Ogura T., Lavin M.F., Esumi H. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J. Biol. Chem. 278:2003;48-53
43. Yang D.O., Kastan M.B. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat. Cell Biol. 2:2000;893-898
44. Concannon P., A Gatti R. Diversity of ATM gene mutations detected in patients with ataxia-telangiectasia. Hum. Mutat. 10:1997;100-107
45. Eng L., Coutinho G., Nahas S., Yeo G., Tanouye R., Babaei M., Dork T., Burge C., Gatti R.A. Non-classical splicing mutations in the coding and non-coding regions of the ATM gene: maximum entropy estimates of splice junction strengths. Hum. Mutat. 23:2004;67-76
46. Dörk T., Bendix R., Bremer M., Rades D., Klopper K., Nicke M., Skawran B., Hector A., Yamini P., Steinmann D., Weise S., Stuhrmann M., Karstens J.H. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. Cancer Res. 61:2001;7608-7615
47. Chenevix-Trench G., Spurdle A.B., Gatei M., Kelly H., Marsh A., Chen X., Donn K., Cummings M., Nyholt D., Jenkins M.A., Scott C., Pupo G.M., Dork T., Bendix R., Kirk J., Tucker K., McCredie M.R., Hopper J.L., Sambrook J., Mann G.J., Khanna K.K. Dominant negative ATM mutations in breast cancer families. J. Natl. Cancer Inst. 94:2002;205-215
48. Thorstenson Y.R., Roxas A., Kroiss R., Jenkins M.A., Yu K.M., Bachrich T., Muhr D., Wayne T.L., Chu G., Davis R.W., Wagner T.M., Oefner P.J. Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res. 63:2003;3325-3333
49. Spring K., Cross S., Li C., Watters D., Ben-Senior L., Waring P., Ahangari F., Lu S.L., Chen P., Misko I., Paterson C., Kay G., Smorodinsky N.I., Shiloh Y., Lavin M.F. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res. 61:2001;4561-4568
50. Barlow C., Hirotsune S., Paylor R., Liyanage M., Eckhaus M., Collins F., Shiloh Y., Crawley J.N., Ried T., Tagle D., Wynshaw-Boris A. Atm-deficient mice: a paradigm of ataxia-telangiectasia. Cell. 86:1996;159-171
51. Xu Y., Ashley T., Brainerd E.E., Bronson R.T., Meyne M.S., Baltimore D. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:1996;2411-2422
52. Spring K., Ahangari F., Scott S.P., Waring P., Purdie D.M., Chen P.C., Hourigan K., Ramsay J., McKinnon P.J., Swift M., Lavin M.F. Mice heterozygous for mutation in ATM, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat. Genet. 32:2002;185-190
53. Paterson M.C., Anderson A.K., Smith B.P., Smith P.J. Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res. 39:1979;3725-3734
54. Su Y., Swift M. Morality rates among carriers of ataxia-telangiectasia mutant alleles. Ann. Inter. Med. 133:2000;770-778
55. Worgul B.V., Smilenov L., Brenner D.J., Junk A., Zhou W., Hall E.J. Atm heterozygous mice are more sensitive to radiation-induced cataracts than are their wild-type counterparts. Proc. Natl. Acad. Sci. U.S.A. 99:2002;9836-9839
56. Li A., Swift M. Mutations at the ataxia-telangiectasia locus and clinical phenotypes of A-T patients. Am. J. Med. Genet. 92:2000;170-177
57. Vorechovsky I., Luo L., Lindblom A., Negrini M., Webster A.D., Croce C.M., Hammarstrom L. ATM mutations in cancer families. Cancer Res. 56:1996;4130-4133
58. Stankovic T., Kidd A.M., Sutcliffe A., McGuire G.M., Robinson P., Weber P., Bedenham T., Bradwell A.R., Easton D.F., Lennox G.G., Haites N., Byrd P.J., Taylor A.M. ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am. J. Hum. Genet. 62:1998;334-345
59. Stewart G.S., Last J.I., Stankovic T., Haites N., Kidd A.M., Byrd P.J., Taylor A.M. Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 576ins137 and 7271T→G mutations, showing a less severe phenotype. J. Biol. Chem. 276:2001;30133-30141
60. Uziel T., Lerenthal Y., Moyal L., Andegeko Y., Mittelman L., Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J. 22:2003;5612-5621
61. Carson C.T., Schwartz R.A., Stracker T.H., Lilley C.E., Lee D.V., Weitzma M.D. The Mre11 complex is required for ATM activation and the G (2)/M checkpoint. EMBO J. 24:2003;6610-6620
62. Petrini J.H. The Mre11 complex and ATM: collaborating to navigate S phase. Curr. Opin. Cell Biol. 12:2000;293-296
63. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H., Taylor A.M. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 99:1999;577-587
64. Zhao S., Weng Y.C., Yuan S.S., Lin Y.T., Hsu H.C., Lin S.C., Gerbino E., Song M.H., Zdzienicka M.Z., A Gatti R., Shay J.W., Ziv Y., Shiloh Y., Lee E.Y. Functional link between ataxia-telangiectasia and Nijmegen breakagae syndrome gene products. Nature. 405:2000;473-477
65. Gatei M., Young D., Cerosaletti K.M., Desai-Mehta A., Spring K., Kozlov S., Lavin M.F., Gatti R.A., Concannon P., Khanna K. ATM-dependent phosphorylation of nibrin in reponse to radiation exposure. Nat. Genet. 1:2000;115-119
66. D'Amours D., Jackson S.P. The Mre11 complex: at the crossroads of DNA repair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3:2002;317-327
67. Tauchi H., Matsuura S., Kobayashi J., Sakamoto S., Komatsu K. Nijmegen breakage syndrome gene, NBS1, and molecular links to factors for genome stability. Oncogene. 21:2002;8967-8980
68. Buscemi G., Savio C., Zannini L., Micciche F., Masnada D., Nakanishi M., Tauchi H., Komatsu K., Mizutani S., Khanna K., Chen P., Concannon P., Chessa L., Delia D. Chk2 activation dependence on Nbs1 after DNA damage. Mol. Cell Biol. 21:2001;5214-5222
69. Kim J.S., Krasieva T.B., LaMorte V., Taylor A.M., Yokomori K. Specific recruitment of human cohesin to laser-induced DNA damage. J. Biol. Chem. 277:2002;45149-45153
70. Yazdi P.T., Wang Y., Zhao S., Patel N., Lee E.Y., Qin J. SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint. Genes Dev. 16:2002;571-582
71. Gatei M., Sloper K., Sorensen C., Syljuasen R., Falck J., Hobson K., Savage K., Lukas J., Zhou B.B., Bartek J., Khanna K.K. Ataxia-telangiectasia mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation. J. Biol. Chem. 278:2003;14806-14811
72. Lukas C., Falck J., Bartkova J., Bartek J., Lukas J. Distinct spatiotemporal dynamics of mammalian checkpoint regulators induced by DNA damage. Nat. Cell Biol. 5:2003;255-260
73. Lee J.H., Xu B., Lee C.H., Ahn J.Y., Song M.S., Lee H., Canman C.E., Lee J.S., Kastan M.B., Lim D.S. Distinct functions of Nijmegen breakage syndrome in ataxia telangiectasia mutated-dependent responses to DNA damage. Mol. Cancer Res. 1:2003;674-681